Irina Pateva MD

Dr. Irina Pateva MD


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
BLBryony Lucas
Bryony Lucas
SRSanjita Ravishankar
Sanjita Ravishankar
IMIrina Pateva MD
Irina Pateva MD
The liver is the third most common site of abdominal tumors in children. This review article aims to summarize current evidence surrounding identification and diagnosis of primary hepatic tumors in the pediatric population based upon clinical presentation, epidemiology, and risk factors as well as classical imaging, histopathological, and molecular diagnostic findings. Readers will be able to recognize the features and distinguish between benign and malignant hepatic tumors within different age groups.

1 January 2017 in Medicine
Verified
Journal Article
Open access
IMIrina Pateva MD
Irina Pateva MD
RERachel A. Egler
Rachel A. Egler
DSDuncan S. Stearns
Duncan S. Stearns
Hepatoblastoma is a rare malignancy. Approximately 100 cases are diagnosed yearly in the United States. The highest incidence occurs in infants and in children younger than 5 years. Cases involving patients older than 5 years are very rare. We describe the case of a patient who was diagnosed with hepatoblastoma at an atypical age of presentation for this type of malignancy. We also performed Ovid MEDLINE search for hepatoblastoma and epidemiology reports occurring in children between the ages of 5 and 18 years. In this article we review the epidemiology and summarize case reports published between 1997 and 2012 of patients with hepatoblastoma, who were older than 5 years. Our patient is an 11 year old boy with stage IV hepatoblastoma with lung and omental metastases at diagnosis. The patient received 7 cycles of chemotherapy following the treatment plan of COG protocol AHEP 0731, off study. He also had tumor resection and omentectomy and achieved complete remission. He later had disease recurrence and after undergoing treatment with different modalities, ultimately died of his disease. Review of SEER program data shows that the incidence of hepatoblastoma in children above the age of 5 years is too infrequent to be calculated. Literature review revealed 13 cases of patients diagnosed at age older than 5 years. Most cases were published due to unusual associations and/or complications. There are no obvious unifying characteristics for these cases, although there may be a slight male preponderance and many patients in this selected series presented with elevated Alpha-fetoprotein. The reported case is rare, given the very low incidence of hepatoblastoma outside of infancy. A systematic review of characteristics and outcomes for patients older than 5 years who are enrolled in cooperative group hepatoblastoma trials may reveal important information about the epidemiology and tumor biology in this rare patient population.

8 April 2015
Verified
Closed access
IMIrina Pateva MD
Irina Pateva MD
EKElizabeth H. Kerling
Elizabeth H. Kerling
MRManju Reddy
Manju Reddy
DCDan Chen
Dan Chen
SCSusan E. Carlson
Susan E. Carlson
JTJakica Tancabelic
Jakica Tancabelic

23 September 2022 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
MMMaria Claudia Moncaliano
Maria Claudia Moncaliano
AMAnita Mahadevan
Anita Mahadevan
JLJessica C. Liu
Jessica C. Liu
INIlora Naik
Ilora Naik
IMIrina Pateva MD
Irina Pateva MD